Fresenius Medical Care AG (FMCQF) Net Cash Flow (2009 - 2026)

Fresenius Medical Care AG has reported Net Cash Flow for 18 years, with the latest figure at -$209.2 million in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 125.96% year-over-year to -$209.2 million in Q2 2026; TTM through Jun 2026 was $426.5 million, a 74.2% decrease from a year earlier, with the FY2025 full-year figure at $646.3 million, up 325.61% from the prior year.
• Net Cash Flow was -$209.2 million for Q2 2026 at Fresenius Medical Care AG, up from -$443.3 million in the prior quarter.
• The five-year high for Net Cash Flow was $1.6 billion in Q4 2025, with the low at -$523.4 million in Q3 2025.
• Average Net Cash Flow over 5 years is $175.3 million, with a median of $17.5 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Net Cash Flow slumped 1167.17% in 2024, then surged 1133.92% in 2025.
• Over 5 years, Net Cash Flow stood at $872.4 million in 2022, then retreated by 26.45% to $641.6 million in 2023, then dropped by 3.44% to $619.6 million in 2024, then soared by 158.63% to $1.6 billion in 2025, then plunged by 113.06% to -$209.2 million in 2026.
• The last three Net Cash Flow figures came in at -$209.2 million (Q2 2026), -$443.3 million (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.